CTI BioPharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
CTI BioPharma to Present at the 41st Annual J.P. Morgan Healthcare Conference PR Newswire SEATTLE , Jan. 5, 2023 /PRNewswire/ — CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will present a corporate overview at more...
Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh
Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh PR Newswire Technologies Licensed from University of Pittsburgh May Have the Potential to Provide Long-Term Efficacy and to Change the Course of more...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TIG, SESN, CBIO
NEW YORK, NY / ACCESSWIRE / January 5, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary more...
STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Catalyst Biosciences, Inc. – CBIO
STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Catalyst Biosciences, Inc. – CBIO STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Catalyst Biosciences, Inc. – CBIO PR Newswire NEW more...
SHAREHOLDER ALERT: Weiss Law Investigates Catalyst Biosciences, Inc.
SHAREHOLDER ALERT: Weiss Law Investigates Catalyst Biosciences, Inc. PR Newswire NEW YORK , Jan. 4, 2023 /PRNewswire/ — Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board more...
CLASS ACTION UPDATE for EIGR, AFRM and SGLY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / January 4, 2023 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as more...
ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX
NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential civil securities claims on behalf of shareholders of BioLineRx Ltd. (NASDAQ: BLRX) more...
Eiger BioPharmaceuticals Class Action Deadline: Submit Your Losses to Johnson Fistel
The Class Action Seeks to Recover Damages on EIGR Shareholders’ Behalf SAN DIEGO, Jan. 04, 2023 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on more...
Checkpoint Therapeutics Submits Biologics License Application to FDA for Cosibelimab as a Treatment for Patients with Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma
Positive and clinically meaningful pivotal clinical results announced in 2022 in both metastatic and locally advanced indications WALTHAM, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and more...
Akari Therapeutics to Present at Biotech Showcase(TM) 2023
NEW YORK and LONDON, Jan. 04, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that Akari President and CEO Rachelle more...